SyedSaqibAliIIIMD

Oncology • Hartford, CT

Hematologic Oncology

Attending Physician

Join to view full profile

Dr. Ali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ali's full profile

Already have an account?

Office
114 Woodland St
Smilow/Yale Saint Francis Cancer Ct
Hartford, CT 06105
Phone+1 860-714-4680

Fax+1 860-714-8047
Is this information wrong?

Education & Training

University of ConnecticutFellowship, Hematology and Medical Oncology, 2006 - 2009
University of ConnecticutResidency, Internal Medicine, 2003 - 2006
University of Connecticut School of MedicineInternship, Transitional Year, 2002 - 2003
King Edward Medical UniversityClass of 1999

Certifications & Licensure

CT State Medical License 2019 - 2024
MA State Medical License 2009 - 2020
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma Start of enrollment: 2008 Apr 01
Active, not recruiting
Phase 3
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Start of enrollment: 2004 Sep 21
Completed
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos Start of enrollment: 2011 Jan 01
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Impact of cardiovascular comorbidities on inpatient mortality in patients hospitalized with neutropenic fever.
Suheil Albert Atallah-Yunes, Anis John Kadado, Faris Haddadin, Khalid Sawalha, Jaime Hernandez-Montfort, Syed S. Ali> ;Supportive Care in Cancer. 2021 Jan 1
2 citations
Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Suheil Albert Atallah-Yunes, Dermot Murphy, Romany Abdelmalak, Luke Mantle, Syed S. Ali> ;European Journal of Haematology. 2019 Sep 30
1 citations
A Rare Case of Extramedullary Relapse of Multiple Myeloma Causing Bowel Obstruction.
Prarthna V Bhardwaj, Shrinkhala Khanna, Majd D. Jawad, Syed S. Ali> ;Case Reports in Hematology. 2019 Apr 11
1 citations
The first reported case of vincristine-induced unilateral vocal cord palsy in an adult patient with HIV-associated Burkitt-like lymphoma being treated with dose-escala...
Leena T. Rahmat, Philip H. Brandt, Syed S. Ali> ;Clinical Case Reports. 2019 Feb 1
1 citations
A rare case of hepatosplenic gamma-delta T-cell lymphoma and secondary hemophagocytic lymphohistiocytosis.
Philip H. Brandt, Leena T. Rahmat, Syed S. Ali> ;Clinical Case Reports. 2019 Jan 1
10 citations
MRI and PET Image Fusion Using Fuzzy Logic and Image Local Features
Umer Javed, Muhammad Mohsin Riaz, Abdul Ghafoor, Syed Sohaib Ali, Tanveer Ahmed Cheema> ;Thescientificworldjournal. 2014 Jan 19
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Saint Francis Hospital and Medical CenterHartford, Connecticut
Baystate Medical CenterSpringfield, Massachusetts